Marc Ferrante

64PUBLICATIONS
150CO-AUTHORS
Innate immunityMolecular targetsImmunogenetics (incl. genetic immunology)PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Sep 25, 2026
Distinct intestinal eosinophil subsets in ulcerative colitis and their modulation by advanced inflammatory bowel disease therapies.

|Sep 11, 2026
Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

|Jul 23, 2026
Patient Preferences for Inflammatory Bowel Disease Treatment: Results from a Global Survey Conducted in Partnership with the European Federation of Crohn's & Ulcerative Colitis Associations.

|Apr 08, 2026
Why the Assay Matters in Model-Informed Precision Dosing: An Example of Ustekinumab in Crohn's Disease.

Wei Zhang, Zhigang Wang, Thierry Dervieux

|Mar 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis.

Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif

|Dec 23, 2025
Multi-stakeholder validation of an evidence-based core set of quality indicators for IBD in Belgium.

Liselotte Fierens, Frank E Rademakers, Peter Bossuyt

Pageof 11

Frequent Collaborators

28 joint publications

Bram Verstockt

25 joint publications

Séverine Vermeire

9 joint publications

João Sabino

6 joint publications

Erwin Dreesen